| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $133.1M | +11.9% |
| SG&A Expense | $48.3M | -7.8% |
| Operating Income | -$199.9M | -16.8% |
| Pre-tax Income | -$190.5M | -12.8% |
| Income Tax | -$126K | +52.5% |
| Net Income | -$190.4M | -12.9% |
| EPS (Basic) | -$1.83 | +16.8% |
| EPS (Diluted) | -$1.83 | +16.8% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $90.1M | -15.1% |
| Short-term Investments | $93.8M | -26.5% |
| Current Assets | $187.6M | -22.8% |
| Total Assets | $190.8M | -31.1% |
| Current Liabilities | $28.4M | +16.6% |
| Total Liabilities | $45.0M | -14.4% |
| Stockholders' Equity | $145.8M | -35.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$124.5M | +12.4% |
| Investing Cash Flow | $38.0M | +147.2% |
| Financing Cash Flow | $70.5M | -44.5% |